or Try an Advanced Search...

    Keratosis Stocks List

    Symbol Grade Name % Change
    ACRS F Aclaris Therapeutics, Inc. -8.96
    BHC F Bausch Health Companies Inc. -5.13
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Dermatology Acne Actinic Keratosis Atopic Dermatitis Biotechnology Chemical Substances Colitis Common Warts Contact Lens Dermatitis Diarrhea Eye Gastroenterology Gastrointestinal Generic Pharmaceutical Generic Pharmaceuticals Hair Removal Health Products Hydrogen Hydrogen Peroxide

    Related ETFs - A few ETFs which own one or more of the above listed Keratosis stocks.

    Symbol Grade Name Weight
    FLHY A Franklin Liberty High Yield Corporate ETF 1.16
    BTEC D Principal Healthcare Innovators Index ETF 0.05
    IWC C iShares Microcap ETF 0.02
    IBBQ C Invesco Nasdaq Biotechnology ETF 0.01
    IBB D iShares Nasdaq Biotechnology Index Fund 0.01
    View all Keratosis ETFs...
    Compare ETFs
    Compare BTEC to IBBQ Compare FLHY to IBBQ Compare IWC to IBB

        Keratosis Stocks Recent News

        Date Stock Title
        May 8 ACRS Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Q1 2024 Earnings Call Transcript
        May 8 ACRS Q1 2024 Aclaris Therapeutics Inc Earnings Call
        May 8 ACRS Aclaris Therapeutics Inc (ACRS) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights ...
        May 8 ACRS Aclaris Therapeutics, Inc. (ACRS) Q1 2024 Earnings Call Transcript
        May 7 ACRS Aclaris Therapeutics (ACRS) Reports Q1 Loss, Tops Revenue Estimates
        May 7 ACRS Aclaris Therapeutics GAAP EPS of -$0.24 beats by $0.03, revenue of $2.4M beats by $0.4M
        May 7 ACRS Aclaris Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
        May 7 BHC Why Bausch Health Stock Plunged After Posting First Quarter 2024 Results
        May 6 ACRS Aclaris Therapeutics Q1 2024 Earnings Preview
        May 6 BHC Bausch Health Companies (NYSE:BHC investor three-year losses grow to 72% as the stock sheds US$388m this past week
        May 3 BHC Bausch + Lomb Corporation (NYSE:BLCO) Q1 2024 Earnings Call Transcript
        May 3 BHC Bausch Health Companies Inc. (NYSE:BHC) Q1 2024 Earnings Call Transcript
        May 3 BHC Bausch (BHC) Q1 Earnings and Revenues Miss, Shares Fall
        May 2 BHC Why Bausch Health Companies Stock Dived by More Than 7% Today
        May 2 BHC Bausch Health Companies (BHC) Q1 2024 Earnings Call Transcript
        May 2 BHC Bausch Health Companies Inc. 2024 Q1 - Results - Earnings Call Presentation
        May 2 BHC Bausch Health Companies Inc Reports Q1 2024 Earnings: A Detailed Analysis Compared to Analyst ...
        May 2 BHC Bausch Health (BHC) Q1 Earnings and Revenues Miss Estimates
        May 2 BHC Bausch Health Companies GAAP EPS of -$0.17, revenue of $2.15B
        May 2 BHC Bausch Health Announces First Quarter 2024 Results
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Dermatology Acne Actinic Keratosis Atopic Dermatitis Biotechnology Chemical Substances Colitis Common Warts Contact Lens Dermatitis Diarrhea Eye Gastroenterology Gastrointestinal Generic Pharmaceutical Generic Pharmaceuticals Hair Removal Health Products Hydrogen Hydrogen Peroxide
        Keratosis

        Keratosis (from kerat- + -osis) is a growth of keratin on the skin or on mucous membranes stemming from keratinocytes, the prominent cell type in the epidermis. More specifically, it can refer to:

        actinic keratosis (also known as solar keratosis)
        chronic scar keratosis
        hydrocarbon keratosis
        keratosis pilaris (KP, also known as follicular keratosis)
        seborrheic keratosisActinic keratoses are pre-malignant growths. Seborrheic keratoses are not pre-malignant.

        More about Keratosis
        Browse All Tags